These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12659469)

  • 1. Impact of gender on renal disease: the role of the renin angiotensin system.
    Kang AK; Miller JA
    Clin Invest Med; 2003 Feb; 26(1):38-44. PubMed ID: 12659469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gender on the renin-angiotensin system, blood pressure, and renal function.
    Kang AK; Miller JA
    Curr Hypertens Rep; 2002 Apr; 4(2):143-51. PubMed ID: 11884270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex and the renin angiotensin system: implications for gender differences in the progression of kidney disease.
    Sandberg K; Ji H
    Adv Ren Replace Ther; 2003 Jan; 10(1):15-23. PubMed ID: 12616459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of gender in the progression of renal disease.
    Silbiger SR; Neugarten J
    Adv Ren Replace Ther; 2003 Jan; 10(1):3-14. PubMed ID: 12616458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease.
    Lawson CR; Doulton TW; MacGregor GA
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):139-45. PubMed ID: 17094050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review: Sex specific programming: a critical role for the renal renin-angiotensin system.
    Moritz KM; Cuffe JS; Wilson LB; Dickinson H; Wlodek ME; Simmons DG; Denton KM
    Placenta; 2010 Mar; 31 Suppl():S40-6. PubMed ID: 20116093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in the renin-angiotensin and nitric oxide systems: relevance in the normal and diseased kidney.
    McGuire BB; Watson RW; Pérez-Barriocanal F; Fitzpatrick JM; Docherty NG
    Kidney Blood Press Res; 2007; 30(2):67-80. PubMed ID: 17268203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual blockade of the renin-angiotensin system in the progression of renal disease: the need for more clinical trials.
    Fernandez-Juárez G; Barrio V; de Vinuesa SG; Goicoechea M; Praga M; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S250-4. PubMed ID: 17130270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hormone therapy on blood pressure and the renin-angiotensin system in postmenopausal women.
    Prime DD; Brosnihan KB; Herrington DM
    Minerva Cardioangiol; 2007 Aug; 55(4):477-85. PubMed ID: 17653023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of renin-angiotensin blockade in patients receiving dialysis.
    Suzuki H
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):397-405. PubMed ID: 19491138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous delivery of PTH/PTHrP type 1 receptor cDNA to rats decreases heart rate, blood pressure, renal tone, renin angiotensin system, and stress-induced cardiovascular responses.
    Fritsch S; Lindner V; Welsch S; Massfelder T; Grima M; Rothhut S; Barthelmebs M; Helwig JJ
    J Am Soc Nephrol; 2004 Oct; 15(10):2588-600. PubMed ID: 15466263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease.
    Raij L
    Am J Hypertens; 2005 Apr; 18(4 Pt 2):95S-99S. PubMed ID: 15837551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of polymorphism in renin angiotensin system and other related genes in South Indian chronic kidney disease patients.
    Anbazhagan K; Sampathkumar K; Ramakrishnan M; Gomathi P; Gomathi S; Selvam GS
    Clin Chim Acta; 2009 Aug; 406(1-2):108-12. PubMed ID: 19520069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for combining blockers of the renin-angiotensin system.
    Azizi M; Wuerzner G
    Semin Nephrol; 2007 Sep; 27(5):544-54. PubMed ID: 17868792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadal steroids, salt-sensitivity and renal function.
    Pechere-Bertschi A; Burnier M
    Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):16-21. PubMed ID: 17143066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes.
    Sochett EB; Cherney DZ; Curtis JR; Dekker MG; Scholey JW; Miller JA
    J Am Soc Nephrol; 2006 Jun; 17(6):1703-9. PubMed ID: 16672313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.
    Weir MR
    J Hum Hypertens; 2007 Oct; 21(10):770-9. PubMed ID: 17597800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.